Stay updated on Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, with links to official status pages. - Updated version to v3.2.0; removed prior v3.1.0.SummaryDifference11%

- Check29 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

- Check43 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, replacing the old revision label. The 'Back to Top' element was removed as a minor UI cleanup.SummaryDifference0.7%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.7%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference22%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.